Tuesday, 22 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14467
Articles
Company
Drug
Eli Lilly’s Retevmo Meets Primary Endpoint in Phase III Trial for RET-mutant Medullary Thyroid Cancer
November 24, 2024
Company
Drug
FDA Grants Priority Review to Pfizer and Astellas’ Xtandi for High-Risk Prostate Cancer
November 24, 2024
Company
Legal / IP
Scott-Moncrieff & Associates Preparing 50 Cases Against AstraZeneca Over Vaccine Concerns
November 24, 2024
Company
Drug
Nanjing F&S Pharmatech Secures First Generic Approval for Novartis’s Entresto in China
November 24, 2024
Company
WuXi Biologics Reports 17.8% Revenue Growth and Expands Service Scope in H1 2023
November 24, 2024
Company
Johnson & Johnson Completes Spinoff of Kenvue as Independent Company
November 24, 2024
Company
Everest Medicines Reports Q1 2023 Revenue Growth and Pipeline Progress
November 24, 2024
Company
Drug
Lynk Pharmaceuticals’ LNK01001 Shows Positive Results in Ankylosing Spondylitis Phase II Study
November 25, 2024
Company
Drug
Allist Pharmaceuticals’ Furmonertinib Wins NMPA Nod for EGFR-Mutated NSCLC Treatment
November 24, 2024
Company
Drug
Zai Lab’s Repotrectinib Targets Breakthrough Therapy Designation for TRK-Positive Tumors
November 24, 2024
Company
Deals
Hangzhou Minsheng Healthcare Aims to Raise RMB890 Million in Shenzhen GEM IPO
November 24, 2024
Company
Drug
RemeGen’s Telitacicept Shows Positive Phase III Results in Rheumatoid Arthritis Study
November 24, 2024
1
2
…
903
904
905
906
907
…
1,205
1,206
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?